1. Home
  2. BHAT vs TXMD Comparison

BHAT vs TXMD Comparison

Compare BHAT & TXMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

BHAT

Blue Hat Interactive Entertainment Technology

HOLD

Current Price

$0.07

Market Cap

27.7M

ML Signal

HOLD

Logo TherapeuticsMD Inc.

TXMD

TherapeuticsMD Inc.

HOLD

Current Price

$2.26

Market Cap

25.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BHAT
TXMD
Founded
2010
2008
Country
China
United States
Employees
N/A
N/A
Industry
Recreational Games/Products/Toys
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
27.7M
25.9M
IPO Year
2018
2012

Fundamental Metrics

Financial Performance
Metric
BHAT
TXMD
Price
$0.07
$2.26
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
2.7M
67.7K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
80.61
EPS
N/A
N/A
Revenue
N/A
$1,761,000.00
Revenue This Year
N/A
$427.09
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$90.64
Revenue Growth
N/A
35.25
52 Week Low
$0.02
$0.72
52 Week High
$3.94
$2.95

Technical Indicators

Market Signals
Indicator
BHAT
TXMD
Relative Strength Index (RSI) 15.06 49.59
Support Level N/A $1.05
Resistance Level $2.05 $2.54
Average True Range (ATR) 0.11 0.16
MACD -0.05 -0.03
Stochastic Oscillator 1.04 33.19

Price Performance

Historical Comparison
BHAT
TXMD

About BHAT Blue Hat Interactive Entertainment Technology

Blue Hat Interactive Entertainment Technology is focused on commodity trading, including chemicals, jewelry, and precious metals such as gold. It operates a gold and diamond trading and supply chain business. Its business model encompasses physical gold trading, diamond trading, gold derivatives trading, and the development of AI-enabled trading platforms. Its segments include Diamond trading, Commodity trading, Information service, Interactive toys - animation series, and Interactive toys - game series. It derives revenue from Diamond trading. The majority of its revenues are generated in PRC.

About TXMD TherapeuticsMD Inc.

TherapeuticsMD Inc is a pharmaceutical royalty company, currently receiving royalties on products licensed to pharmaceutical organizations that possess commercial capabilities in the relevant territories. The company and its subsidiaries (i) granted Mayne Pharma an exclusive license to commercialize its IMVEXXY, BIJUVA and prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brands (collectively, the "Licensed Products") in the United States and its possessions and territories, (ii) assigned to Mayne Pharma its exclusive license to commercialize ANNOVERA (together with the Licensed Products, collectively, the "Products") in the United States and its possessions and territories.

Share on Social Networks: